Big Pharma Will Target Smaller Deals in 2020, JPMorgan Predicts

(Bloomberg) -- Big U.S. drugmakers made some splashy deals over the past year, with Bristol-Myers Squibb Co. snapping up Celgene for more than $70 billion and AbbVie Inc. agreeing to take over Alle...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.